A Study of PYX-201 in Combination With Pembrolizumab in People With Solid Tumor Cancer

Full Title

A Phase 1/2, Open-label, Global, Multicenter, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX-201 in Combination with Pembrolizumab in Participants with Advanced Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Winston Wong’s office at 646-608-4245.

Protocol
26-195
Phase
Phase I/II (phases 1 and 2 combined)
Disease Status
Newly Diagnosed & Relapsed/Refractory
Investigator
Winston Wong
Co-Investigators
Alan L. Ho
Diseases
Head & Neck Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06795412
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description